semaglutide menopause weight Postmenopausal women on the GLP-1 medication tirzepatide (Zepbound) for obesity lost more if they were also using hormone therapy, a retrospective cohort study indicated. https://www.medpagetoday.com/endocrinology/menopause/119594 Ozempic and Menopause: Weight, Risks

This will ensure a longer effect and less irritation

Caffeine prevents d-galactose-induced cognitive deficits, oxidative stress, neuroinflammation and neurodegeneration in the adult rat brain

Injection-site reactions: redness, swelling, or irritation (generally mild and transient) [11]

In October 2023, A Research Study to See How Semaglutide Works Compared to Placebo in People with Type 2 Diabetes and Chronic Kidney Disease (FLOW) trial assessing the effect of semaglutide versus placebo on the progression of renal impairment in people with T2DM and chronic kidney disease was stopped prematurely due to results of an interim analysis showing significant efficacy of semaglutide with full results due to be released in the first half of 2024 [39]

[PMID: 5360727] PubMed record related to this compound for laboratory literature review

Adverse events are underreported or attributed to user error